Clinical Trial

HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
It is aimed to investigate the responses of Fatty Acid Binding Protein 4 (FABP4), which has been discovered as a novel biomarker of obesity and metabolic diseases, to regular exercise training. The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Trial Details
NCT Number NCT06973980
Lead Sponsor Eastern Mediterranean University
Conditions High-Intensity Interval Training
Enrollment 28 participants
Start Date 2025-03-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-15